Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NKPD1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | SERPINA9 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
mRNA | ALS2CL | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | ZFP82 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | PAPD7 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
mRNA | GATA6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | CCNI | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
mRNA | INSR | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | ZNF117 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | CEP164 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |